10-101065003-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_030929.5(KAZALD1):​c.*83G>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.115 in 998,274 control chromosomes in the GnomAD database, including 7,997 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.096 ( 1002 hom., cov: 33)
Exomes 𝑓: 0.12 ( 6995 hom. )

Consequence

KAZALD1
NM_030929.5 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.296

Publications

5 publications found
Variant links:
Genes affected
KAZALD1 (HGNC:25460): (Kazal type serine peptidase inhibitor domain 1) This gene encodes a secreted member of the insulin growth factor-binding protein (IGFBP) superfamily. The protein contains an insulin growth factor-binding domain in its N-terminal region, a Kazal-type serine protease inhibitor and follistatin-like domain in its central region, and an immunoglobulin-like domain in its C-terminal region. Studies of the mouse ortholog suggest that this protein may function in bone development and bone regeneration. This gene is hypomethylated and over-expressed in high-grade glioma compared to low-grade glioma, and thus the hypomethylated gene may be associated with cell proliferation and the shorter survival of patients with high-grade glioma. It is also one of numerous genes found to be deleted in a novel 5.54 Mb interstitial deletion, which is associated with multiple congenital anomalies. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.175 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KAZALD1NM_030929.5 linkc.*83G>T 3_prime_UTR_variant Exon 5 of 5 ENST00000370200.6 NP_112191.2 Q96I82-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KAZALD1ENST00000370200.6 linkc.*83G>T 3_prime_UTR_variant Exon 5 of 5 1 NM_030929.5 ENSP00000359219.6 Q96I82-1
KAZALD1ENST00000477979.5 linkn.654G>T non_coding_transcript_exon_variant Exon 4 of 4 3
KAZALD1ENST00000477267.1 linkn.453+60G>T intron_variant Intron 4 of 4 5

Frequencies

GnomAD3 genomes
AF:
0.0959
AC:
14583
AN:
152130
Hom.:
1000
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0220
Gnomad AMI
AF:
0.0976
Gnomad AMR
AF:
0.0969
Gnomad ASJ
AF:
0.101
Gnomad EAS
AF:
0.00308
Gnomad SAS
AF:
0.186
Gnomad FIN
AF:
0.214
Gnomad MID
AF:
0.0510
Gnomad NFE
AF:
0.123
Gnomad OTH
AF:
0.0932
GnomAD4 exome
AF:
0.119
AC:
100436
AN:
846026
Hom.:
6995
Cov.:
11
AF XY:
0.121
AC XY:
53405
AN XY:
439908
show subpopulations
African (AFR)
AF:
0.0199
AC:
425
AN:
21356
American (AMR)
AF:
0.115
AC:
4150
AN:
36110
Ashkenazi Jewish (ASJ)
AF:
0.0945
AC:
1972
AN:
20872
East Asian (EAS)
AF:
0.00130
AC:
46
AN:
35370
South Asian (SAS)
AF:
0.175
AC:
12142
AN:
69550
European-Finnish (FIN)
AF:
0.214
AC:
10535
AN:
49294
Middle Eastern (MID)
AF:
0.0637
AC:
224
AN:
3514
European-Non Finnish (NFE)
AF:
0.117
AC:
66687
AN:
570046
Other (OTH)
AF:
0.107
AC:
4255
AN:
39914
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
4580
9160
13740
18320
22900
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1532
3064
4596
6128
7660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0958
AC:
14592
AN:
152248
Hom.:
1002
Cov.:
33
AF XY:
0.0999
AC XY:
7436
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.0219
AC:
910
AN:
41542
American (AMR)
AF:
0.0972
AC:
1488
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.101
AC:
352
AN:
3470
East Asian (EAS)
AF:
0.00289
AC:
15
AN:
5186
South Asian (SAS)
AF:
0.185
AC:
893
AN:
4826
European-Finnish (FIN)
AF:
0.214
AC:
2269
AN:
10596
Middle Eastern (MID)
AF:
0.0548
AC:
16
AN:
292
European-Non Finnish (NFE)
AF:
0.123
AC:
8357
AN:
68008
Other (OTH)
AF:
0.0960
AC:
203
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
654
1308
1963
2617
3271
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
180
360
540
720
900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.102
Hom.:
1186
Bravo
AF:
0.0817
Asia WGS
AF:
0.131
AC:
455
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.42
DANN
Benign
0.48
PhyloP100
-0.30
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12359843; hg19: chr10-102824760; COSMIC: COSV64630078; COSMIC: COSV64630078; API